• Second-Chance Sampling allows you to apply more blood to help prevent wasting test strips and to save money

  • CONTOUR® NEXT TEST STRIPS

    CONTOUR® NEXT blood glucose test strips offer a simple solution for your testing needs with No Coding technology - proven accuracy - fast test time - and small blood sample.

    NO CODING TECHNOLOGY

    No Coding Technology eleminates errors due to user miscoding.

  • CONTOUR® NEXT TEST STRIPS

    CONTOUR® NEXT blood glucose test strips offer a simple solution for your testing needs with No Coding technology - proven accuracy - fast test time - and small blood sample.

    5-SECOND COUNTDOWN

    With CONTOUR® NEXT test strips, you can see your results after a 5-second countdown.

  • CONTOUR® NEXT TEST STRIPS

    CONTOUR® NEXT blood glucose test strips offer a simple solution for your testing needs with No Coding technology - proven accuracy - fast test time - and small blood sample.

    SMALL BLOOD SAMPLE

    You only need a tiny 0.6 μL blood sample for CONTOUR® and CONTOUR®NEXT test strips.

Easy-to-use features on CONTOUR® and CONTOUR® NEXT test strips

  • No Coding  technology means one less step in testing and eliminates errors due to user miscoding 
  • Sip-In® Sampling quickly sips in your blood sample
  • Automatic compensation for many common interfering substances (such as acetaminophen and vitamin C)

CONTOUR®NEXT test strips

  • Exclusively used with the CONTOUR®NEXT meters
  • High-performance test strips with proven accuracy
  • Second-Chance sampling allows you to apply more blood to help prevent wasting test strips which can help you save money
  • No Coding™ technology means one less step in testing and eliminates errors due to a user miscoding
  • MULTIPULSE™ accuracy technology evaluates the sample multiple times to ensure highly accurate results 
  • Tiny 0.6 µL blood sample
  • 5-second countdown 

CONTOUR® test strips

  • Compatible with CONTOUR®, CONTOUR® USB and CONTOUR® LINK meters
  • Tiny 0.6 µL blood sample
  • 5-second test time

BREEZE®2 test strips

  • Compatible with the BREEZE®2 meter
  • Easy to use, 10-Test Disc eliminates fumbling with individual test strips
  • Small 1.0 µL blood sample
  • 5-second test time

Eligible patients may save up to $105* every month on CONTOUR® NEXT test strips with CONTOUR® Choice.

Learn More

* Valid for up to 12 months of refills through 12/31/2017. Offer not valid on 25 count test strips. ELIGIBLE PRIVATELY INSURED PATIENTS pay the first $15 of co-pay on Rx of 300 test strips or less. CASH PATIENTS can receive savings up to $25 per month. RESTRICTIONS: Offer not valid for prescriptions reimbursed under Medicaid, Medicare drug benefit plan, Tricare or other federal or state health programs (i.e. medical assistance programs). If patient is eligible for drug benefits under any such program, offer not valid. Visit ContourChoice.com for additional benefit details and Restrictions. Void where prohibited. For Questions: Call 1-855-226-3931. Patient: BY USING THIS CARD, YOU UNDERSTAND AND AGREE TO COMPLY WITH THE RESTRICTIONS. YOU ALSO CERTIFY THAT YOU WILL COMPLY WITH ANY TERMS OF YOUR HEALTH INSURANCE CONTRACT REQUIRING THAT YOUR PAYOR BE NOTIFIED OF THE EXISTENCE AND/OR VALUE OF THIS OFFER. Pharmacist: By applying this offer, you are certifying that you have not submitted a claim for reimbursement under any federal, state, or other governmental programs for this prescription, and that you will comply with the Restrictions. Participation in this program must comply with all applicable laws and regulations as a pharmacy provider. Pharmacist instructions for a patient with an Eligible Third Party: Submit claim to the primary Third Party Payer first, then submit the balance due to Therapy First as a Secondary Payer COB [coordination of benefits] with patient responsibility amount and a valid Other Coverage Code, (e.g. 8). Patient is responsible for the first $15 and the card covers up to $35 of remaining co-pay on prescriptions of 300 test strips or less. For quantities over 300 test strips, patient contributions and card benefits increase accordingly – up to $45 and $105 respectively. Reimbursement will be received from Therapy First. Pharmacist instructions for a cash paying patient: Submit this claim to Therapy First. A valid Other Coverage Code (e.g. 1) is required. Patient is responsible for the first $15 and the card covers up to $25 per month. Reimbursement will be received from Therapy First. Valid Other Coverage Code required. For any questions regarding Therapy First online processing, please call the Help Desk at 1-800-422-5604. Offer expires 12/31/17.

CONTOUR® NEXT test strips

The CONTOUR® and BREEZE®2 testing platforms offer No Coding technology, as well as no maltose and galactose interference.

CONTOUR® NEXT test strips help ensure accuracy

  • No Coding technology means one less step in testing and eliminates errors due to user miscoding 
  • GDH-FAD (CONTOUR®) and GO (BREEZE®2) testing platforms do not interfere with maltose and galactose - two of the non-glucose sugars cited in a 2009 FDA public health notice 1*
  • Interfering products containing non-glucose sugars include:
    • Extraneal (icodextrin) peritoneal dialysis solution
    • Some immunoglobulins
    • Orencia® (abatacept)
    • Adept® adhesion reduction solution(4% icodextrin)
    • BEXXAR® radioimmunotherapy agent

Neither BREEZE®2 (GO) nor CONTOUR® (GDH-FAD) testing platforms use GDH-PQQ chemistry. Testing devices that use GDH-PQQ chemistry can report falsely elevated blood glucose result due to non-glucose sugar interference, which can lead to serious injury or death. Visit http://www.fda.gov/%20MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm176992.htm for more information.

1. US Food and Drug Administration. FDA Public Health Notification: Potentially fatal errors with GDH-PQQ glucose monitoring technology. August 13, 2009.
Orencia is a registered trademark of Bristol-Myers Squibb.
Adept is a registered trademark of Innovata plc.
BEXXAR is a registered trademark of GlaxoSmithKline.

*The CONTOUR® and CONTOUR®NEXT test strips with GDH-FAD chemistry cross-react with Xylose. Do not use CONTOUR® or CONTOUR®NEXT test strips during or shortly after a xylose absorption test.

CONTOUR®NEXT Test Strips

  • Exclusively used with Bayer’s family of CONTOUR®NEXT meters
  • Meets ISO 15197:2013 accuracy requirements
  • Shown to provide high accuracy by combining the following:
    • Advanced algorithm: corrects signals from various sources of error, including temperature, hematocrit, and user technique
    • MULTIPULSE™ accuracy technology: evaluates the sample multiple times to ensure highly accurate results. 
    • Proprietary mediator: provides increased stability for proven accuracy

International Organization for Standardization. In vitro diagnostic test systems—requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva, Switzerland: International Organization for Standardization; 2013.

CONTOUR® Test Strips

These strips are used with the CONTOUR® USB meter, CONTOUR® meter  and the CONTOUR® LINK meter. Automatic accuracy with CONTOUR® test strips. No Coding™ technology self codes when the strip is inserted, eliminating inaccurate readings due to user miscoding.

  • Unaffected by maltose, galactose, and oxygen*
  • Automatic correction for common interfering substances such as acetaminophen, ascorbic acid and hematocrit
  • Fast 5-second test time
  • Small 0.6-µL blood sample

BREEZE®2 Multi-test Disc

This multi-test disc is used with the BREEZE®2 family of meters. Fewer steps with the unique 10-test disc. No Coding technology self codes when the disc is inserted, eliminating inaccurate readings due to user miscoding.

Easy-to-use 10-test disc eliminates handling individual test strips

  • Unaffected by maltose and galactose**
  • Fast 5-second test time
  • Small 1.0-µL blood sample


*Affected by xylose, Do not use during or soon after xylose absorption testing.
**Glucose oxidase test strip chemistry; affected by oxygen.